
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation
Rafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 805-813
Open Access | Times Cited: 9
Rafael Paternostro, Mathias Jachs, Lukas Hartl, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 805-813
Open Access | Times Cited: 9
Showing 9 citing articles:
Primary prophylaxis of acute variceal bleeding in patients with severe cirrhosis: Time for combination therapy?
Marika Rudler
Journal of Hepatology (2025)
Closed Access
Marika Rudler
Journal of Hepatology (2025)
Closed Access
FAST and Agile–the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin
Mădălina-Gabriela Țâru, Cristian Tefas, Lidia Neamți, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303971-e0303971
Open Access | Times Cited: 3
Mădălina-Gabriela Țâru, Cristian Tefas, Lidia Neamți, et al.
PLoS ONE (2024) Vol. 19, Iss. 5, pp. e0303971-e0303971
Open Access | Times Cited: 3
A robust clustering strategy for stratification unveils unique patient subgroups in acutely decompensated cirrhosis
Sara Palomino‐Echeverría, Estefanía Huergo, Asier Ortega-Legarreta, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Sara Palomino‐Echeverría, Estefanía Huergo, Asier Ortega-Legarreta, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease
Elba Llop, José Luís Calleja
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 824-825
Open Access | Times Cited: 2
Elba Llop, José Luís Calleja
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 824-825
Open Access | Times Cited: 2
Medikamentöse Therapie der portalen Hypertension
Anna Martin, Tobias Goeser, Philipp Kasper
DMW - Deutsche Medizinische Wochenschrift (2024) Vol. 149, Iss. 07, pp. 386-395
Closed Access
Anna Martin, Tobias Goeser, Philipp Kasper
DMW - Deutsche Medizinische Wochenschrift (2024) Vol. 149, Iss. 07, pp. 386-395
Closed Access
β-BLOCKERS LOWER FIRST DECOMPENSATION IN PATIENTS WITH CIRRHOSIS AND ENDURING PORTAL HYPERTENSION AFTER ETIOLOGICAL TREATMENT
Laura Turco, Mădălina-Gabriela Țâru, Giovanni Vitale, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access
Laura Turco, Mădălina-Gabriela Țâru, Giovanni Vitale, et al.
Clinical Gastroenterology and Hepatology (2024)
Open Access
Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease—Authors' reply
Rafael Paternostro, Mathias Jachs, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 826-827
Open Access | Times Cited: 1
Rafael Paternostro, Mathias Jachs, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 826-827
Open Access | Times Cited: 1
Letter: NSBB for fatty liver disease—Still a long way to go. Authors' reply
Mathias Jachs, Rafael Paternostro, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 848-849
Open Access
Mathias Jachs, Rafael Paternostro, Thomas Reiberger, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 848-849
Open Access
Letter: NSBB for fatty liver disease—Still a long way to go
Hangfei Xu, Yang Zhang, Jing Zhang
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 847-847
Open Access
Hangfei Xu, Yang Zhang, Jing Zhang
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 8, pp. 847-847
Open Access